• No results found

Saxagliptin for type 2 diabetes

N/A
N/A
Protected

Academic year: 2020

Share "Saxagliptin for type 2 diabetes"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 Structure of saxagliptin and 5-hydroxy saxagliptin.1,5
Table 1 Summary of the effects of saxagliptin 5 mg on glycemic parameters in controlled 24-week clinical trials
Figure 3 Efficacy of saxagliptin in monotherapy, add-on combination therapy, or initial combination therapy in patients with T2D
Table 2 incidence of common adverse events and hypoglycemia in controlled 24-week clinical trials with saxagliptin 5 mg

References

Related documents

It consisted of 14 questions covering the following 5 sections: (i) a general section describing the use of guidelines at the centres including local or international

The system has been criticized as leading to low land use efficiency (Liu et al., 1998); the villagers’ short-term destructive investment in agricultural land (Li, et al.,

Agadatantra, one of the Ashtangas of Ayurveda mentions in detail the concept of Garavisha and Dooshivisha, which are comparable with various sources of exposure of toxins

a) Sämtliche 10 Fzds werden in hMSC im unstimulierten Zustand exprimiert, allerdings in unterschiedlichem Maße. c) Der Knockdown von Fzd1 geht mit einer

So far, there are no clear recommendations for preterm infants on the timing of initiation complementary feeding and few data are available the optimal timing

Denn während die 180 ps-Kinetik von cAMPB so interpretiert werden kann, daß mit dieser Zeit ein Übergang vom angeregten Zustand in die trans-Konformation erfolgt, scheint bei lAMPB

symptoms and caregiver beliefs about selected asth- ma-management practices (see Table 5). Mothers with high levels of depressive symptoms reported significantly more negative

Untreated OSAS can result in serious morbidity. Early reports documented such complications as fail- ure to thrive, cor pulmonale, and mental retarda- tion. 11 These severe